Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________________ Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-37477 _______ ...

Teladoc Health, Inc. (NYSE:TDOC) Q3 2023 Earnings Conference Call October 24, 2023 4:30 PM ET Company Participants Patrick Feeley - Head of Investor Relations Jason Gorevic - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Ryan Daniels - William Blair Jailendra Singh - Truist Richard Close - Canaccord Genuity Lucas Romanski - TD Cowen George Hill - Deutsche Bank Jessica Tassan - Piper Sandler Daniel Grosslight - Citi Elizabeth Anderson - Everco ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________________ Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-37477 ____________ ...

Teladoc Health, Inc. (NYSE:TDOC) Q2 2023 Earnings Call Transcript July 25, 2023 4:30 PM ET Company Participants Patrick Feeley - Head of Investor Relations Jason Gorevic - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Sandy Draper - Guggenheim Jailendra Singh - Truist Securities Lisa Gill - JP Morgan Daniel Grosslight - Citi Sean Dodge - RBC Capital Markets Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity George Hill - Deutsche Bank. Charles Rhyee ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 (State of incorporation) (I.R.S. Employer Identification No.) 2 Manhattanville Road, Suite 203 Purchase, New York ...

Teladoc Health, Inc. (NYSE:TDOC) Q1 2023 Earnings Conference Call April 26, 2023 4:30 PM ET Company Participants Patrick Feeley – Head of Investor Relations Jason Gorevic – Chief Executive Officer Mala Murthy – Chief Financial Officer Conference Call Participants Lisa Gill – J.P. Morgan Sandy Draper – Guggenheim Jack Senft – William Blair Stephanie Davis – SVB Jailendra Singh – Truist Daniel Grosslight – Citi Richard Close – Canaccord Jessica Tassan – Piper Sandler Sean Dodge – RBC Capital Markets Allen Lu ...

Telehealth Services - Teladoc Health completed approximately 18.5 million telehealth visits in 2022 through business-to-business and direct-to-consumer channels[17]. - Over 80 million individuals in the U.S. have access to Teladoc Health's products and services as of December 31, 2022[21]. - The Integrated Care segment generated 87% of total revenue from access fees for the year ended December 31, 2022[22]. - The Integrated Care segment includes a suite of global virtual medical services, focusing on chronic condition management and mental health[19]. - The core platform is capable of supporting upwards of 100,000 visits per day, showcasing its scalability[39]. - Teladoc Health's engagement science utilizes predictive analytics to drive utilization of virtual healthcare services[34]. - The platform complies with international data and privacy regulations, allowing for global service offerings tailored to local needs[42]. - The company has developed a global distribution network, providing 24x7 services to international members from locations in Europe, South America, and Asia[60]. - The integrated mobile app offers a seamless experience for accessing virtual health services, driving increased member engagement and enrollment[56]. - The company has expanded its virtual primary care offering, Primary360, which integrates multi-source data and personalized care plans[52]. - A new offering, Inpatient Connected Care, allows hospitals to utilize patient room televisions for virtual care, addressing staffing shortages with a projected need for 2.1 million new registered nurses by 2025[53]. Mental Health Services - The BetterHelp segment primarily consists of a direct-to-consumer mental health platform with over 30,000 licensed clinicians[20]. - The BetterHelp segment leads the D2C therapy market, with a 25% increase in global anxiety and depression rates during the pandemic, indicating substantial growth potential[62]. - Investments in chronic care management and mental health services, such as myStrength Complete and Chronic Care Complete, aim to improve health outcomes for individuals with multiple chronic conditions[54]. Financial Performance - The company incurred net losses of $13,659.5 million and $428.8 million for the years ended December 31, 2022 and 2021, respectively, with an accumulated deficit of $15,008.3 million as of December 31, 2022[124]. - The company recorded a non-deductible goodwill impairment charge of $6.6 billion in Q1 2022 and an additional $3.0 billion in Q2 2022, totaling $9.6 billion for those two quarters[127]. - An additional $3.8 billion non-cash impairment charge was recognized in Q4 2022, driven by a decline in projected cash flows[128]. - The company anticipates that costs of revenue and operating expenses may continue to increase substantially in the foreseeable future due to ongoing investments in business expansion[125]. - The top ten clients accounted for 19.2% and 21.8% of total revenue for the years ended December 31, 2022 and 2021, respectively, indicating a reliance on a limited number of clients[126]. Regulatory Compliance - The company is subject to various federal and state laws, including the Stark Law, which imposes penalties of up to $27,750 per violation and potential exclusion from federally funded healthcare programs[87]. - Violations of the federal Anti-Kickback Statute can result in civil monetary penalties of up to $112,131 and criminal fines of $100,000 per violation[88]. - The company is also subject to the False Claims Act, with penalties ranging from $12,537 to $25,076 for each false claim, plus triple damages[89]. - HIPAA violations can lead to significant civil and criminal penalties, with a single breach potentially violating multiple standards[95]. - The company is committed to monitoring healthcare regulations to ensure compliance and mitigate risks associated with changing laws[81]. - The company has established systems to ensure that affiliated physicians are appropriately licensed under applicable state law for telehealth services[84]. Diversity and Inclusion - The company is committed to health equity, establishing a Health Equity Task Force and hiring key roles to address disparities in healthcare access[78]. - The company identified a gap in health outcomes for Hispanic members and prioritized the rollout of Spanish-language experiences across its portfolio[79]. - The company has increased accessibility features to accommodate diverse user needs, including those with visual and physical impairments[80]. - The company has enhanced its diversity, equity, and inclusion (DEI) initiatives, including expanding diversity hiring manager training resources and partnerships to advance diverse talent[116]. Growth Strategy - Teladoc Health aims to position virtual care as the first choice for healthcare access, leveraging enterprise scale and technical capabilities[49]. - The company plans to drive growth through selective investments and acquisitions to enhance service offerings and distribution capabilities[63]. - The company expects a significant portion of its revenue to come from the renewal of existing client contracts and sales of additional applications and services to current clients[143]. - The company is executing growth initiatives, including the introduction of new products like virtual primary care, but faces risks that may hinder achieving expected benefits[167]. - Strategic relationships with third parties are crucial for growth, and failure to maintain these relationships could impair revenue growth and competitive positioning[168]. Operational Challenges - The company faces significant competition in the virtual care industry, which may lead to pricing pressures and impact sales and profitability[136]. - Economic uncertainties may negatively affect client demand for solutions, potentially leading to reduced revenue and increased write-offs of accounts receivable[174][177]. - The company must attract and retain qualified personnel, particularly software engineers, to support its growth initiatives[162]. - Challenges in recruiting and retaining healthcare professionals could adversely affect the company's operational performance and growth potential[171]. - The ability to scale solutions for both large and smaller clients is essential, as large clients often require specific features that may strain implementation capacity[163]. International Operations - The company is expanding its international operations, which are subject to stringent legal and regulatory requirements, including anti-corruption laws[106]. - The company faces risks related to international operations, including regulatory approvals, data privacy laws, and competition from local businesses[188]. - Approximately 13% of the company's revenue was generated internationally in 2022, indicating reliance on global markets[186]. Financial Risks - The company may need to incur additional indebtedness or seek capital through new equity or debt financings to support growth and respond to business challenges[205]. - The company’s future capital requirements will depend on growth rate, subscription renewal activity, and market acceptance of virtual care[207]. - Fluctuations in foreign currency exchange rates may adversely affect the company's revenue and expenses, impacting profitability[209]. - The company may face challenges in repatriating earnings due to foreign government restrictions and exchange rate controls[209]. Disaster and Operational Risks - The company faces significant risks from natural or man-made disasters, which could disrupt operations and negatively impact financial condition and results[210]. - Headquarters are located in a disaster-prone area, increasing vulnerability to events like terrorist attacks and hurricanes[210]. - Reliance on third-party data center providers and internet infrastructure poses risks; failures could lead to litigation and damage client relationships[211].

Teladoc Health, Inc. (NYSE:TDOC) Q4 2022 Results Conference Call February 22, 2023 4:30 PM ET Company Participants Patrick Feeley - Head, IR Jason Gorevic - CEO Mala Murthy - CFO Conference Call Participants Lisa Gill - JP Morgan Daniel Grosslight - Citi Elizabeth Anderson - Evercore Jailendra Singh - Truist Securities Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity Stan Berenshteyn - Wells Fargo Stephanie Davis - SVB Securities Operator Good afternoon, and thank you for attending today's T ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 TELADOC HEALTH, INC. (Exact name of registrant as specified in its charter) 2 Manhattanville Road, Suite 203 Purcha ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 TELADOC HEALTH, INC. (Exact name of registrant as specified in its charter) (Address of principal executive office ...